ETF Building Blocks Content Hub Election Impact Could Be Muted, Biotech Still Appealing By Todd ShriberSeptember 29, 2020
ETF Building Blocks Content Hub Acquisitions & Postive Drug Data Boost SBIO ETF Again By Special To VettaFiAugust 25, 2020
ETF Building Blocks Content Hub When Innovation and Being Nimble Matters, Turn to this Biotech ETF By Tom LydonAugust 3, 2020
ETF Building Blocks Content Hub Betting on Biotech With Utility Beyond Covid-19 By Tom LydonJuly 31, 2020
ETF Building Blocks Content Hub Fabulous Fundamentals Brighten Outlook for Healthcare, With This Biotech ETF By Tom LydonJuly 7, 2020
ETF Building Blocks Content Hub Another Round of Coronavirus Cases Puts This Biotech ETF in Focus By Tom LydonJune 29, 2020
ETF Building Blocks Content Hub A Healthcare ETF Could Benefit From Index Reshuffling By Tom LydonJune 23, 2020
ETF Building Blocks Content Hub Biotech ETFs in the Spotlight, Why They’ll Remain There By Tom LydonJune 18, 2020
ETF Building Blocks Content Hub Biotech ETF Doesn’t Need Coronavirus Vaccines to Soar By Tom LydonJune 2, 2020
Disruptive Technology Content Hub A Biotech ETF at the Center of a Profit/Peril Market By Tom LydonFebruary 27, 2020
Thematic Investing Content Hub Smaller Companies, Big Returns For This Biotech ETF By Tom LydonFebruary 21, 2020
Innovative ETFs Content Hub ACADIA Pharmaceuticals Help Lift Biotech ETFs By Max ChenSeptember 9, 2019
Thematic Investing Content Hub Biotech ETFs Jump: Keep an Eye on XBI, IBB & SBIO By Frank HolmanJune 18, 2019
